The association between residual tumor volume after primary cytoreduction and survival was less consistent in patients with low-grade serous ovarian carcinoma (LGSOC) compared with other histology ...

Evidence on the safety of cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis shows frequent and serious but well-recognised complications.

Despite aggressive primary surgical cytoreduction and platinum-based chemotherapy, many women diagnosed with advanced epithelial ovarian cancer who achieve primary remission will experience disease ...

It would not be an exaggeration to state that the goal of attempting to surgically maximally cytoreduce diffuse intraperitoneal ovarian cancer represents one of the most unique standard-of-care ...

Surgery plays a critical role in the optimal management of all stages of ovarian carcinoma. In apparent early-stage ovarian cancer, a comprehensive surgical evaluation allows stratification of ...

Hyperthermic intraperitoneal chemotherapy (HIPEC) provides an important treatment option that can improve survival for some patients with advanced peritoneal cancer. Managing this disease — and ...

Dr. Douglas Tremblay of the Ichan School of Medicine explains the necessity of cytoreductive therapy for patients with MPNs such as essential thrombocythemia and polycythemia vera. Cytoreduction is ...

Researchers from The University of Texas MD Anderson Cancer Center reported that secondary tumor-reduction, or cytoreduction, surgery followed by chemotherapy did not result in longer survival than ...

AI models outperform traditional statistics in predicting post-complete cytoreduction outcomes in ovarian cancer patients. AI's diagnostic accuracy was high for predicting overall survival and no ...

In advanced ovarian cancer, maximal efforts have to be attemptedto achieve optimal cytoreduction, as this represents the keystone in the therapeutic management. This large, prospective study aims at ...

National guidelines recommend primary surgery as the preferred initial treatment for advanced ovarian cancers despite studies showing less perioperative morbidity with neoadjuvant chemotherapy ...

Evidence-based recommendations on cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis. This involves surgically removing visible cancer and ...